Curing metastatic cancer: lessons from testicular germ-cell tumours

@article{Masters2003CuringMC,
  title={Curing metastatic cancer: lessons from testicular germ-cell tumours},
  author={J. Masters and B. K{\"o}berle},
  journal={Nature Reviews Cancer},
  year={2003},
  volume={3},
  pages={517-525}
}
  • J. Masters, B. Köberle
  • Published 2003
  • Biology, Medicine
  • Nature Reviews Cancer
  • Most metastatic cancers are fatal. More than 80% of patients with metastatic testicular germ-cell tumours (TGCTs), however, can be cured using cisplatin-based combination chemotherapy. Why are TGCTs more sensitive to chemotherapeutics than most other tumour types? Answers to this question could lead to new treatments for metastatic cancers. 
    199 Citations

    Figures, Tables, and Topics from this paper

    Explore Further: Topics Discussed in This Paper

    Shedding light on testicular cancer.
    • 4
    Testicular germ-cell cancer
    • 526
    Biology of germ cell tumors.
    • 11
    Third-line chemotherapy and novel agents for metastatic germ cell tumors.
    • 8
    Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer
    • 20
    Molecular mechanisms behind the resistance of cisplatin in germ cell tumours
    • 32
    Treatment of germ cell tumors--update 2006.
    • 9
    Biology of testicular germ cell tumors
    • 18
    Advances in the Treatment of Testicular Cancer
    • 22

    References

    SHOWING 1-10 OF 77 REFERENCES
    Testicular germ-cell cancer.
    • 607
    Molecular determinants of treatment response in human germ cell tumors.
    • F. Mayer, H. Stoop, +4 authors C. Bokemeyer
    • Biology, Medicine
    • Clinical cancer research : an official journal of the American Association for Cancer Research
    • 2003
    • 113
    • PDF
    Curing metastatic testicular cancer
    • L. Einhorn
    • Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 2002
    • 299
    • PDF
    Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways.
    • 62
    Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.
    • 66
    Effects of CIS‐platinum on embryonal carcinoma cell lines in vitro
    • 43
    Role of P53 and MDM2 in treatment response of human germ cell tumors.
    • 78